---
schema_version: "secwatch.filing_event.v1"
accession: "0001789769-23-000095"
form_type: "8-K"
ticker: "TIL"
cik: "0001789769"
company_name: "Instil Bio, Inc."
filed_at: "2023-11-27T23:59:59+00:00"
generated_at: "2026-06-07T21:34:35.544331+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Instil Bio announces 1-for-20 reverse stock split approved by Audit Committee

## Summary
- Audit Committee approved a 1-for-20 reverse stock split, with ratio determined per prior stockholder authorization.
- Approval occurred on November 21, 2023; no effective date disclosed.
- Reverse split follows annual meeting authorization at ratio range of 1-for-10 to 1-for-30.

## SEC filing metadata
- accession: 0001789769-23-000095
- form_type: 8-K
- ticker: TIL
- cik: 0001789769
- company_name: Instil Bio, Inc.
- filed_at: 2023-11-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789769/000178976923000095/0001789769-23-000095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789769/000178976923000095/til-20231121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001789769-23-000095
- JSON: https://secwatch.observer/filing/0001789769-23-000095.json
- Plain text: https://secwatch.observer/filing/0001789769-23-000095.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.